1. From the Division of Biometrics IV, Office of Biostatistics (D.R.), the Division of Antivirals, Office of Infectious Diseases (K.C.-T.), and the Office of Infectious Diseases (J.F., A.S.), Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.